(Adds details from paragraph 4) Oct 30 (Reuters) – European chemicals maker dsm-firmenich lowered its 2025 adjusted core profit guidance on Thursday, citing negative foreign exchange effects and volatility in vitamin prices. The group expects adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) to total 2.3 billion euros ($2.68 billion), compared to a previous estimate of 2.4 billion euros. The new forecast is slightly below the 2.32 billion euros expected by analysts in a company-compiled consensus. While sharpening focus on perfumes and flavours, the group said in February 2024 it planned to carve out its Animal Health and Nutrition unit by the end of this year. That would lower its exposure to vitamins earnings volatility and reduce its capital intensity in line with its long-term strategy, it said at the time. Dsm-firmenich, whose products are used in perfumes made by French luxury groups LVMH and Kering, said it expects to book a 90 million euro cost from adverse exchange rates and 50 million euros from volatile vitamin costs. The company reported adjusted core profit of 540 million euros for the third quarter, in line with analysts' forecast. ($1 = 0.8575 euros) (Reporting by Dimitri Rhodes; Editing by Mrigank Dhaniwala and Eileen Soreng)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
